Bausch Health Companies | VRX - Pre Tax Profit


Bausch Health Companies reported $56M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amgen USD 1.51B 2.41B Dec/2025
ANI Pharmaceuticals USD 31.48M 18.04M Dec/2025
Aurora Cannabis CAD 11.41M 12.99M Mar/2026
Bausch Health Companies USD 56M 162M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Canopy Growth CAD -157.96M 95.71M Mar/2026
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Danaher USD 1.24B 138M Mar/2026
Drreddys Laboratories INR 2B 13.43B Mar/2026
Eli Lilly USD 8.27B 1.03B Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD 571K 8.95M Dec/2025
Perrigo USD -1.33B 1.35B Dec/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Supernus Pharmaceuticals USD -5.95M 4.04M Mar/2026
Vertex Pharmaceuticals USD 1.25B 78.1M Mar/2026
Zoetis USD 761M 126M Dec/2025